Scilex Holding Company Common Stock

SCLXNASDAQUSD
8.90 USD
1.69 (23.44%)AT CLOSE (11:59 AM EDT)
8.80
0.10 (1.11%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
8.80
0.10 (1.11%)
🔴Market: CLOSED
Open?$7.45
High?$9.75
Low?$7.40
Prev. Close?$7.21
Volume?383.2K
Avg. Volume?109.5K
VWAP?$8.64
Rel. Volume?3.50x
Bid / Ask
Bid?$7.30 × 100
Ask?$10.19 × 100
Spread?$2.89
Midpoint?$8.75
Valuation & Ratios
Market Cap?62.6M
Shares Out?8.5M
Float?6.3M
Float %?74.1%
P/E Ratio?N/A
P/B Ratio?-0.30
EPS?-$57.23
Dividend?0.00%
Ex-Dividend?N/A

Scilex Holding Company Common Stock (SCLX) is currently trading at $8.90. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (193.7%) and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of May 29, 2026.

News
Profile
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
Employees
34
Market Cap
62.6M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2022-11-11
Address
960 SAN ANTONIO ROAD
PALO ALTO, CA 94303
Phone: (650) 516-4310
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Neutral(0/3)
Medium-Term (Wave)? Bullish(+2/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
14
Short Sent.?
75
Piotroski F-Score?0/9Weak
Altman Z-Score?-7.98Distress
Confidence?48%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?2.51%Low
Short Interest?158.0K
Days to Cover?1.3
Free Float6.3M
Avg Daily Volume119.2K
Settlement Date2026-05-15
Financial Health
Current Ratio?0.08Weak
Quick Ratio?0.07Weak
Cash Ratio?0.01Low
Debt/Equity?-0.53Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
93/100
P/E?
N/A
P/B?
S&P
97
-0.30CHEAP
P/S?
Peers
100
S&P
65
2.07CHEAP
P/FCF?
Peers
100
S&P
66
17.0CHEAP
EV/EBITDA?
S&P
97
-0.6CHEAP
EV/Sales?
Peers
100
S&P
32
5.52FAIR
Returns & Efficiency
ROE?
Peers
50
S&P
97
193.7%STRONG
ROA?
S&P
3
-110.3%WEAK
Cash Flow & Enterprise
FCF?$3.7M
Enterprise Value?$166.9M
Fundamentals ratios updated end of day